Number of the records: 1
Evaluation of effectiveness and safety of Imodyn medication, produced by Sevafarma JSC, in patients with reactive arthritis caused by Epstein-Barr virus
Title Evaluation of effectiveness and safety of Imodyn medication, produced by Sevafarma JSC, in patients with reactive arthritis caused by Epstein-Barr virus Author info M. Lomikovska, G. Potomkina, V. Hayevska Title Hodnotenie účinnosti a bezpečnosti lieku Immodin, výrobku Sevafarma JSC, u pacientov s reaktívnou artritídou spôsobenou vírusom Epstein-Barrovej Author Lomikovska M.
Co-authors Potomkina G.
Hayevska V.
Corporation Martinské dni imunológie 15., 2017, Martin, Slovensko
Sign. C 2659 Source Klinická imunológia a alergológia. - ISSN 1335-0013. - Bratislava : BONUS C.C.S. , 2017 . - Zv. 27, č. 1 (2017), s. 12 a 14 MeSH Subject artritída reaktívna : diagnostika : imunológia : terapia
herpesvírus ľudí 4
adjuvanciá imunologické
výsledok liečby
Form, Genre abstrakt z kongresu
Subj. Headings Immodin Language English Country Slovak Republic Document kind Rozpis článkov z periodík Database ARTICLES 
article
Number of the records: 1